MedPath

Alginic acid

Generic Name
Alginic acid
Drug Type
Small Molecule
CAS Number
9005-32-7
Unique Ingredient Identifier
8C3Z4148WZ

Overview

Alginic acid, also referred to as algin or alginate, is a hydrophilic or anionic polysaccharide isolated from certain brown seaweed (Phacophycae) via alkaline extraction. It is present in cell walls of brown algae where it forms a viscous gel when binding with water. Alginic acid is a linear polymer consisted of L-glucuronic acid and D-mannuronic acid residues connected via 1,4-glycosidic linkages . Available in different types of salt, alginic acid has been used in a variety of uses in food, cosmetics and pharmaceu-tical products for over 100 years . Alginic acid is an FDA-approved food ingredient in soup and soup mixes as an emulsifier, thickener, and stabilizer . It is also available in oral dietary supplements and is found in antacids such as Gaviscon to inhibit gastroesophageal reflux by creating a physical barrier in presence of gastric acid . Alginate-based raft-forming formulations in the management of heartburn and gastric acid reflux have been used worldwide for over 30 years .

Background

Alginic acid, also referred to as algin or alginate, is a hydrophilic or anionic polysaccharide isolated from certain brown seaweed (Phacophycae) via alkaline extraction. It is present in cell walls of brown algae where it forms a viscous gel when binding with water. Alginic acid is a linear polymer consisted of L-glucuronic acid and D-mannuronic acid residues connected via 1,4-glycosidic linkages . Available in different types of salt, alginic acid has been used in a variety of uses in food, cosmetics and pharmaceu-tical products for over 100 years . Alginic acid is an FDA-approved food ingredient in soup and soup mixes as an emulsifier, thickener, and stabilizer . It is also available in oral dietary supplements and is found in antacids such as Gaviscon to inhibit gastroesophageal reflux by creating a physical barrier in presence of gastric acid . Alginate-based raft-forming formulations in the management of heartburn and gastric acid reflux have been used worldwide for over 30 years .

Indication

Indicated for the management of gastric reflux, reflux oesophagitis, hiatus hernia, heartburn (including heartburn of pregnancy) and similar gastric distress .

Associated Conditions

  • Dyspepsia
  • Flatulence
  • Gastro-esophageal Reflux Disease (GERD)
  • Gastroesophageal Reflux
  • Heartburn
  • Reflux Acid
  • Reflux Esophagitis (RE)
  • Regurgitation

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

GAVISCON PEPPERMINT TABLETS
Manufacturer:RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Form:TABLET, CHEWABLE
Strength:250MG
Online:Yes
Approved: 2011/04/14
Approval:SIN13947P
GASCOVID LIQUID
Manufacturer:Hovid Berhad
Form:SUSPENSION
Strength:500 mg/10ml
Online:Yes
Approved: 2020/11/17
Approval:SIN16041P
GAVISCON ADVANCE-PEPPERMINT FLAVOUR SUSPENSION
Manufacturer:RECKITT BENCKISER HEALTHCARE (UK) LTD
Form:SUSPENSION
Strength:1000 mg/10 ml
Online:Yes
Approved: 2004/12/24
Approval:SIN12635P
GAVISCON LIQUID SACHETS
Manufacturer:RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Form:SUSPENSION
Strength:500MG/10ML
Online:Yes
Approved: 2009/11/23
Approval:SIN13738P
GAVISCON DOUBLE ACTION LIQUID, SUSPENSION
Manufacturer:RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Form:SUSPENSION
Strength:500MG/10ML
Online:Yes
Approved: 2011/09/19
Approval:SIN14016P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath